Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1998 Jan;93(1):73–79. doi: 10.1046/j.1365-2567.1998.00390.x

Effect of granulocyte-macrophage colony-stimulating factor on the number of leucocytes and course of Listeria monocytogenes infection in naive and leucocytopenic mice.

A M Buisman 1, J A Langermans 1, R van Furth 1
PMCID: PMC1364108  PMID: 9536121

Abstract

This study concerns the effect of recombinant murine granulocyte-macrophage colony-stimulating factor (GM-CSF) on the number of circulating leucocytes, activation of peritoneal macrophages and proliferation of Listeria monocytogenes in various organs of naive and leucocytopenic mice. Mice were rendered leucocytopenic by sublethal total body irradiation or cyclophosphamide treatment. GM-CSF treatment enhanced the number of granulocytes and monocytes in peripheral blood during L. monocytogenes infection in naive mice, but not in irradiated or cyclophosphamide-treated mice. In naive mice, irradiated and cyclophosphamide-treated mice, GM-CSF did not affect the course of L. monocytogenes infection in thigh muscle, spleen and liver. However, GM-CSF treatment significantly increased the number of macrophages in the peritoneal cavity of naive mice during infection; these macrophages were more enlarged and showed a higher frequency of binucleated and multinucleated cells relative to non-GM-CSF-treated mice. Together, these results demonstrated that GM-CSF increased the number of circulating granulocytes and monocytes, and the number of peritoneal macrophages during infection with L. monocytogenes in naive mice, but did not affect the course of the infection in thigh muscle, spleen or liver of these mice. In leucocytopenic mice, however, GM-CSF did not affect the number of circulating phagocytes, which explains that this factor had no effect on the proliferation of the bacteria in the various organs.

Full text

PDF
73

Images in this article

77Figure 2
on p.77
77Figure 3
on p.77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Buckley M., Sathe Y. S., Freireich E. J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966 Feb;64(2):328–340. doi: 10.7326/0003-4819-64-2-328. [DOI] [PubMed] [Google Scholar]
  2. Cannistra S. A., Vellenga E., Groshek P., Rambaldi A., Griffin J. D. Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood. 1988 Mar;71(3):672–676. [PubMed] [Google Scholar]
  3. Coleman D. L., Chodakewitz J. A., Bartiss A. H., Mellors J. W. Granulocyte-macrophage colony-stimulating factor enhances selective effector functions of tissue-derived macrophages. Blood. 1988 Aug;72(2):573–578. [PubMed] [Google Scholar]
  4. Conlan J. W., North R. J. Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium. J Exp Med. 1991 Sep 1;174(3):741–744. doi: 10.1084/jem.174.3.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Denis M. Colony-stimulating factors increase resistance to atypical mycobacteria in resistant mice, whereas they decrease resistance in susceptible strains of mice. J Leukoc Biol. 1991 Sep;50(3):296–302. doi: 10.1002/jlb.50.3.296. [DOI] [PubMed] [Google Scholar]
  6. Fischer H. G., Frosch S., Reske K., Reske-Kunz A. B. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J Immunol. 1988 Dec 1;141(11):3882–3888. [PubMed] [Google Scholar]
  7. Gasson J. C. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood. 1991 Mar 15;77(6):1131–1145. [PubMed] [Google Scholar]
  8. Greil J., Bodendorfer B., Röllinghoff M., Solbach W. Application of recombinant granulocyte-macrophage colony-stimulating factor has a detrimental effect in experimental murine leishmaniasis. Eur J Immunol. 1988 Oct;18(10):1527–1533. doi: 10.1002/eji.1830181009. [DOI] [PubMed] [Google Scholar]
  9. Groopman J. E., Molina J. M., Scadden D. T. Hematopoietic growth factors. Biology and clinical applications. N Engl J Med. 1989 Nov 23;321(21):1449–1459. doi: 10.1056/NEJM198911233212106. [DOI] [PubMed] [Google Scholar]
  10. Harmenberg J., Höglund M., Hellström-Lindberg E. G- and GM-CSF in oncology and oncological haematology. Eur J Haematol Suppl. 1994;55:1–28. doi: 10.1111/j.1600-0609.1994.tb01617.x. [DOI] [PubMed] [Google Scholar]
  11. Kaufman S. E., DiPersio J. F., Gasson J. C. Effects of human GM-CSF on neutrophil degranulation in vitro. Exp Hematol. 1989 Aug;17(7):800–804. [PubMed] [Google Scholar]
  12. Kunst M. W., Mattie H. Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli. J Infect Dis. 1978 Apr;137(4):391–402. doi: 10.1093/infdis/137.4.391. [DOI] [PubMed] [Google Scholar]
  13. MACKANESS G. B. Cellular resistance to infection. J Exp Med. 1962 Sep 1;116:381–406. doi: 10.1084/jem.116.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mayer P., Schütze E., Lam C., Kricek F., Liehl E. Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice. J Infect Dis. 1991 Mar;163(3):584–590. doi: 10.1093/infdis/163.3.584. [DOI] [PubMed] [Google Scholar]
  15. Metcalf D., Begley C. G., Williamson D. J., Nice E. C., De Lamarter J., Mermod J. J., Thatcher D., Schmidt A. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp Hematol. 1987 Jan;15(1):1–9. [PubMed] [Google Scholar]
  16. Metcalf D., Elliott M. J., Nicola N. A. The excess numbers of peritoneal macrophages in granulocyte-macrophage colony-stimulating factor transgenic mice are generated by local proliferation. J Exp Med. 1992 Apr 1;175(4):877–884. doi: 10.1084/jem.175.4.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Monroy R. L., Skelly R. R., Taylor P., Dubois A., Donahue R. E., MacVittie T. J. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol. 1988 Jun;16(5):344–348. [PubMed] [Google Scholar]
  18. Nathan C. F. Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood. 1989 Jan;73(1):301–306. [PubMed] [Google Scholar]
  19. Rogers H. W., Unanue E. R. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun. 1993 Dec;61(12):5090–5096. doi: 10.1128/iai.61.12.5090-5096.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Southwick F. S., Purich D. L. Intracellular pathogenesis of listeriosis. N Engl J Med. 1996 Mar 21;334(12):770–776. doi: 10.1056/NEJM199603213341206. [DOI] [PubMed] [Google Scholar]
  21. Stanley E., Lieschke G. J., Grail D., Metcalf D., Hodgson G., Gall J. A., Maher D. W., Cebon J., Sinickas V., Dunn A. R. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5592–5596. doi: 10.1073/pnas.91.12.5592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tanaka T., Okamura S., Okada K., Suga A., Shimono N., Ohhara N., Hirota Y., Sawae Y., Niho Y. Protective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic mice. Infect Immun. 1989 Jun;57(6):1792–1799. doi: 10.1128/iai.57.6.1792-1799.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Vadas M. A., Nicola N. A., Metcalf D. Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. J Immunol. 1983 Feb;130(2):795–799. [PubMed] [Google Scholar]
  24. Weisbart R. H., Kacena A., Schuh A., Golde D. W. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature. 1988 Apr 14;332(6165):647–648. doi: 10.1038/332647a0. [DOI] [PubMed] [Google Scholar]
  25. Wexler L. H., Weaver-McClure L., Steinberg S. M., Jacobson J., Jarosinski P., Avila N., Pizzo P. A., Horowitz M. E. Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy. J Clin Oncol. 1996 Mar;14(3):901–910. doi: 10.1200/JCO.1996.14.3.901. [DOI] [PubMed] [Google Scholar]
  26. van Dissel J. T., Stikkelbroeck J. J., Michel B. C., van den Barselaar M. T., Leijh P. C., van Furth R. Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. J Immunol. 1987 Sep 1;139(5):1673–1678. [PubMed] [Google Scholar]
  27. van Waarde D., Hulsing-Hesselink E., van Furth R. A serum facted by newborn calf serum. Cell Tissue Kinet. 1976 Jan;9(1):51–63. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES